Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SURGICAL ADJUVANT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 373 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Neven, P; Vergote, G
      Tamoxifen, screening and new oestrogen receptor modulators

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    2. Fabian, CJ
      Breast cancer chemoprevention: beyond tamoxifen

      BREAST CANCER RESEARCH
    3. Harris, S
      Breast cancer management. 6. Radiotherapy for early and advanced breast cancer

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    4. Chodak, GW; Kolvenbag, GJCM
      Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?

      PROSTATE CANCER AND PROSTATIC DISEASES
    5. Bundred, NJ; Chan, K; Anderson, NG
      Studies of epidermal growth factor receptor inhibition in breast cancer

      ENDOCRINE-RELATED CANCER
    6. Lonning, PE; Sorlie, T; Perou, CM; Brown, PO; Botstein, D; Borresen-Dale, AL
      Microarrays in primary breast cancer - lessons from chemotherapy studies

      ENDOCRINE-RELATED CANCER
    7. Skinner, KA; Silverstein, MJ
      The management of ductal carcinoma in situ of the breast

      ENDOCRINE-RELATED CANCER
    8. Greenberger, LM; Annable, T; Collins, KI; Komm, BS; Lyttle, CR; Miller, CP; Satyaswaroop, PG; Zhang, YX; Frost, P
      A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats

      CLINICAL CANCER RESEARCH
    9. Silverstein, MJ; Parker, SH; Silverstein, MJ; Grotting, JC; Cote, RJ; Russell, CA
      Ductal carcinoma in situ (DCIS) of the breast: Diagnostic and therapeutic controversies

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    10. Cody, HS; Klauber-DeMore, N; Borgen, PI; Van Zee, KJ
      Is it really duct carcinoma in situ?

      ANNALS OF SURGICAL ONCOLOGY
    11. Anthony, T; Jones, C; Antoine, J; Sivess-Franks, S; Turnage, R
      The effect of treatment for colorectal cancer on long-term health-related quality of life

      ANNALS OF SURGICAL ONCOLOGY
    12. Guerrieri-Gonzaga, A; Baglietto, L; Johansson, H; Bonanni, B; Robertson, C; Sandri, MT; Canigiula, L; Lampreda, C; Diani, S; Lien, EA; Decensi, A
      Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    13. Hoque, A; Lippman, SM; Boiko, IV; Atkinson, EN; Sneige, N; Sahin, A; Weber, DM; Risin, S; Lagios, MD; Schwarting, P; Colburn, WJ; Dhingra, K; Follen, M; Kelloff, GJ; Boone, CW; Hittelman, WN
      Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    14. Julian, TB
      MRI: A role in clinical trials

      JOURNAL OF MAGNETIC RESONANCE IMAGING
    15. Zhong, MH; Lu, ZM; Abbas, T; Hornia, A; Chatakondu, K; Barile, N; Kaplan, P; Foster, DA
      Novel tumor-promoting property of tamoxifen

      CELL GROWTH & DIFFERENTIATION
    16. Wolff, AC
      Systemic therapy

      CURRENT OPINION IN ONCOLOGY
    17. Retsas, S
      Adjuvant therapy of malignant melanoma: is there a choice?

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    18. Takeda, A; Shigematsu, N; Kondo, M; Amemiya, A; Kawaguchi, O; Katsuki, S; Ishibashi, R; Kawata, T; Masago, K; Fukada, J; Kubo, A
      Breast-conserving therapy for ductal carcinoma in situ

      ONCOLOGY REPORTS
    19. Wood, WC
      Surgery and staging for ductal carcinoma in situ

      BREAST
    20. Silverstein, MJ
      Biologic variables and prognosis in patients with ductal carcinoma in situof the breast

      BREAST
    21. Spittle, MF
      Systemic treatments for ductal carcinoma in situ

      BREAST
    22. Pritchard, KI
      Optimal endocrine therapy

      BREAST
    23. Cutuli, B; Cohen-Solar-Le Nir, C; De Lafontan, B; Mignotte, H; Fichet, V; Fay, R; Servent, V; Giard, S; Charra-Brunaud, C; Auvray, H; Penault-Llorca, F; Charpentier, JC
      Ductal carcinoma in situ of the breast results of conservative and radicaltreatments in 716 patients

      EUROPEAN JOURNAL OF CANCER
    24. Ringberg, A; Anagnostaki, L; Anderson, H; Idvall, I; Ferno, M
      Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics

      EUROPEAN JOURNAL OF CANCER
    25. Garattini, S; La Vecchia, C
      Perspectives in cancer chemotherapy

      EUROPEAN JOURNAL OF CANCER
    26. Lohrisch, C; Piccart, MJ
      Standard medical treatment for early breast cancer

      EUROPEAN JOURNAL OF CANCER
    27. Cook, LS; Weiss, NS; Pharris-Ciurej, N; Schwartz, SM; White, E
      Colorectal cancer following tamoxifen therapy for breast cancer (United States)

      CANCER CAUSES & CONTROL
    28. Tavassoli, FA
      Ductal intraepithelial neoplasia of the breast

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    29. Kohne, CH; Grothey, A; Bokemeyer, C; Bontke, N; Aapro, M
      Chemotherapy in elderly patients with colorectal cancer

      ANNALS OF ONCOLOGY
    30. Umemoto, A; Komaki, K; Monden, Y; Suwa, M; Kanno, Y; Kitagawa, M; Suzuki, M; Lin, CX; Ueyama, Y; Momen, MA; Ravindernath, A; Shibutani, S
      Identification and quantification of tamoxifen-DNA adducts in the liver ofrats and mice

      CHEMICAL RESEARCH IN TOXICOLOGY
    31. Armstrong, DK; Davidson, NE
      Dose intensity for breast cancer

      ONCOLOGY-NEW YORK
    32. Small, W; Lurie, RH
      Current status of radiation in the treatment of breast cancer

      ONCOLOGY-NEW YORK
    33. Kimmick, GG; Muss, HB
      Systemic therapy for older women with breast cancer

      ONCOLOGY-NEW YORK
    34. Krishnan, K; Brenner, DE
      Prostaglandin inhibitors and the chemoprevention of noncolonic malignancy

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    35. Olivotto, I; Levine, M
      Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update)

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    36. Levine, M; Moutquin, JM; Walton, R; Feightner, J
      Chemoprevention of breast cancer - A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    37. Jha, MK; Avlonitis, VS; Griffith, CDM; Lennard, TWJ; Wilson, RG; McLean, LM; Dawes, PD; Shrimankar, J
      Aggressive local treatment for screen-detected DCIS results in very low rates of recurrence

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    38. Anan, K; Mitsuyama, S; Tamae, K; Nishihara, K; Iwashita, T; Abe, Y; Ihara, T; Nakahara, S; Katsumoto, F; Toyoshima, S
      Pathological features of mucinous carcinoma of the breast are favourable for breast-conserving therapy

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    39. Poller, DN
      Pathology of ductal carcinoma in situ of the breast: current status

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    40. Bijker, N; Rutgers, EJT; Peterse, JL; Fentiman, IS; Julien, JP; Duchateau, L; van Dongen, JA
      Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    41. Dhingra, K
      Selective estrogen receptor modulation: The search for an ideal hormonal therapy for breast cancer

      CANCER INVESTIGATION
    42. Buchholz, TA; Tucker, SL; Erwin, J; Mathur, D; Strom, EA; McNeese, MD; Hortobagyi, GN; Cristofanilli, M; Esteva, FJ; Newman, L; Singletary, SE; Buzdar, AU; Hunt, KK
      Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy

      JOURNAL OF CLINICAL ONCOLOGY
    43. Bijker, N; Peterse, JL; Duchateau, L; Julien, JP; Fentiman, IS; Duval, C; Di Palma, S; Simony-Lafontaine, J; de Mascarel, I; van de Vijver, MJ
      Risk factors for recurrence and metastasis after breast-conserving therapyfor ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853

      JOURNAL OF CLINICAL ONCOLOGY
    44. Recht, A; Edge, SB; Solin, LJ; Robinson, DS; Estabrook, A; Fine, RE; Fleming, GF; Formenti, S; Hudis, C; Kirshner, JJ; Krause, DA; Kuske, RR; Langer, AS; Sledge, GW; Whelan, TJ; Pfister, DG
      Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology

      JOURNAL OF CLINICAL ONCOLOGY
    45. Lippman, SM; Spitz, MR
      Lung cancer chemoprevention: An integrated approach

      JOURNAL OF CLINICAL ONCOLOGY
    46. Vogel, VG
      Reducing the risk of breast cancer with tamoxifen in women at increased risk

      JOURNAL OF CLINICAL ONCOLOGY
    47. Swain, SM
      Tamoxifen for patients with estrogen receptor-negative breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    48. Wickerham, DL
      Ductal carcinoma-in-situ

      JOURNAL OF CLINICAL ONCOLOGY
    49. Goldhirsch, A; Glick, JH; Gelber, RD; Coates, AS; Senn, HJ
      Meeting highlights: International consensus panel on the treatment of primary breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    50. Piccart, MJ; Di Leo, A; Beauduin, M; Vindevoghel, A; Michel, J; Focan, C; Tagnon, A; Ries, F; Gobert, P; Finet, C; Closon-Dejardin, MT; Dufrane, JP; Kerger, J; Liebens, F; Beauvois, S; Bartholomeus, S; Dolci, S; Lobelle, JP; Paesmans, M; Nogaret, JM
      Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    51. Kornek, GV
      Cancer treatment in the elderly

      ONKOLOGIE
    52. White, INH
      Anti-oestrogenic drugs and endometrial cancers

      TOXICOLOGY LETTERS
    53. Hann, LE; Gretz, EM; Bach, AM; Francis, SM
      Sonohysterography for evaluation of the endometrium in women treated with tamoxifen

      AMERICAN JOURNAL OF ROENTGENOLOGY
    54. Solin, LJ; Fourquet, A; Vicini, FA; Haffty, B; Taylor, M; McCormick, B; McNeese, M; Pierce, LJ; Landmann, C; Olivotto, IA; Borger, J; Kim, JS; de la Rochefordiere, A; Schultz, DJ
      Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: Long-term outcome and prognostic significance of patient age and margin status

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    55. Salih, AK; Fentiman, IS
      Breast cancer prevention: present and future

      CANCER TREATMENT REVIEWS
    56. Clemons, M; Danson, S; Hamilton, T; Goss, P
      Locoregionally recurrent breast cancer: incidence, risk factors and survival

      CANCER TREATMENT REVIEWS
    57. Zhou, Q; Hopp, T; Fuqua, SAW; Steeg, PS
      Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment

      CANCER LETTERS
    58. Vrscaj, MU; Kovacic, J; Bebar, S; Djurisic, A; Fras, PA; Robic, V
      Endometrial and other primary cancers after tamoxifen treatment of breast cancer - results of retrospective cohort study

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    59. Gori, S; Mosconi, AM; Tabilio, A; Falzetti, F; Aristei, C; Basurto, C; Cherubini, R; Latini, P; Martelli, MF; Tonato, M; Colozza, M
      Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients

      TUMORI
    60. Sakorafas, GH
      Breast cancer surgery - Historical evolution, current status and future perspectives

      ACTA ONCOLOGICA
    61. Viens, P; Roche, H; Kerbrat, P; Fumoleau, P; Guastalla, JP; Delozier, T
      Epirubicin-docetaxel combination in first-line chemotherapy for patients with metastatic breast cancer - Final results of a dose-finding and efficacystudy

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    62. Wang, X; Tang, J; Wu, J; Feng, J; Pang, L; Dai, A; Zheng, X
      Preoperative high-dose chemotherapy with peripheral blood stem cell support as a primary management of locally advanced breast cancer

      BONE MARROW TRANSPLANTATION
    63. Kurtz, JM
      Which patients don't need a tumor-bed boost after whole-breast radiotherapy?

      STRAHLENTHERAPIE UND ONKOLOGIE
    64. Sautter-Bihl, ML
      Simultaneous lobular carcinoma in situ is no contraindication for breat conserving therapy in patients with invasive breast cancer

      STRAHLENTHERAPIE UND ONKOLOGIE
    65. Balducci, L; Extermann, M
      A practical approach to the older patient with cancer

      CURRENT PROBLEMS IN CANCER
    66. Phillips, DH
      Understanding the genotoxicity of tamoxifen?

      CARCINOGENESIS
    67. White, INH; Carthew, P; Davies, R; Styles, J; Brown, K; Brown, JE; Smith, LL; Martin, EA
      Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but doesnot lead to liver tumours in female Wistar/Han rats

      CARCINOGENESIS
    68. Divi, RL; Dragan, YP; Pitot, HC; Poirier, MC
      Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen

      CARCINOGENESIS
    69. van Leeuwen, FE; Bergman, L; Beelen, MLR; Gallee, MPW; Hollema, H
      Tamoxifen and risk of endometrial cancer - Reply

      LANCET
    70. Ganz, PA
      The role of hormones in breast carcinogenesis: Issues of relevance to female childhood cancer survivors

      MEDICAL AND PEDIATRIC ONCOLOGY
    71. Hortobagyi, GN
      Optimal duration of therapy with trastuzumab

      SEMINARS IN ONCOLOGY
    72. Mamounas, EP; Fisher, B
      Preoperative (neoadjuvant) chemotherapy in patients with breast cancer

      SEMINARS IN ONCOLOGY
    73. Recht, A
      Postmastectomy locoregional radiotherapy: Is it here to stay?

      SEMINARS IN ONCOLOGY
    74. Ganz, PA
      Menopause and breast cancer: Symptoms, late effects, and their management

      SEMINARS IN ONCOLOGY
    75. Coleman, RE; Seaman, JJ
      The role of zoledronic acid in cancer: Clinical studies in the treatment and prevention of bone metastases

      SEMINARS IN ONCOLOGY
    76. Isaacs, C; Stearns, V; Hayes, DF
      New prognostic factors for breast cancer recurrence

      SEMINARS IN ONCOLOGY
    77. Lee, JD; Lieberman, R; Sloan, JA; Piantadosi, S; Lippman, SM
      Design considerations for efficient prostate cancer chemoprevention trials

      UROLOGY
    78. Wenzel, C; Schmidinger, M; Huber, H
      Has there been progress in pharmacotherapy for breast cancer patients?

      WIENER KLINISCHE WOCHENSCHRIFT
    79. Dalton, RR; Kallab, AM
      Chemoprevention of breast cancer

      SOUTHERN MEDICAL JOURNAL
    80. Fong, K; Kung, R; Lytwyn, A; Trudeau, M; Chapman, W; Nugent, P; Glanc, P; Manchul, L; Szabunio, D; Myhr, T
      Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen

      RADIOLOGY
    81. Mourits, MJE; De Vries, EGE; Willemse, PHB; Ten Hoor, KA; Hollema, H; Van der Zee, AGJ
      Tamoxifen treatment and gynecologic side effects: A review

      OBSTETRICS AND GYNECOLOGY
    82. Kuerer, HM; Buzdar, AU; Singletary, SE
      Biologic basis and evolving role of aromatase inhibitors in the managementof invasive carcinoma of the breast

      JOURNAL OF SURGICAL ONCOLOGY
    83. Vicini, FA; Kestin, LL; Goldstein, NS; Baglan, KL; Pettinga, JE; Martinez, AA
      Relationship between excision volume, margin status, and tumor size with the development of local recurrence patients with ductal carcinoma-in-situ treated with breast-conserving therapy

      JOURNAL OF SURGICAL ONCOLOGY
    84. Green, AR; Parrott, EL; Butterworth, M; Jones, PS; Greaves, P; White, INH
      Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus

      JOURNAL OF ENDOCRINOLOGY

    85. Tamoxifen and endometrial cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
    86. Kubatka, P; Bojkova, B; Mocikova-Kalicka, K; Mnichova-Chamilova, M; Adamekova, E; Ahlers, I; Ahlersova, E; Cermakova, M
      Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats

      FOLIA BIOLOGICA
    87. Medich, D; McGinty, J; Parda, D; Karlovits, S; Davis, C; Caushaj, P; Lembersky, B
      Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma - Pathologic findings and clinical implications

      DISEASES OF THE COLON & RECTUM
    88. Bordeleau, L; Rakovitch, E; Naimark, DM; Pritchard, KI; Ackerman, I; Sawka, GA
      A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis

      CANCER
    89. Solin, LJ; Fourquet, A; Vicini, FA; Haffty, B; Taylor, M; McCormick, B; McNeese, N; Pierce, LJ; Landmann, C; Olivotto, IA; Borger, J; de la Rochefordiere, A; Schultz, DJ
      Salvage treatment for local recurrence after breast-conserving surgery andradiation as initial treatment for mammographically detected ductal carcinoma in site of the breast

      CANCER
    90. Stewart, JH
      Lung carcinoma in African Americans - A review of the current literature

      CANCER
    91. Chan, KC; Knox, WF; Sinha, G; Gandhi, A; Barr, L; Baildam, AD; Bundred, NJ
      Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ

      CANCER CYTOPATHOLOGY
    92. Chan, KC; Knox, WF; Sinha, G; Gandhi, A; Barr, L; Baildam, AD; Bundred, NJ
      Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ

      CANCER
    93. Smith, RA; von Eschenbach, AC; Wender, R; Levin, B; Byers, T; Rothenberger, D; Brooks, D; Creasman, W; Cohen, C; Runowicz, C; Saslow, D; Cokkinides, V; Eyre, H
      American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers - ALSO: Update 2001 - Testing for early lung cancer detection

      CA-A CANCER JOURNAL FOR CLINICIANS
    94. Denoux, Y; Marnay, J; Crouet, H; Boute, V; Delozier, T; Vie, B; Chasle, J
      Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature

      BULLETIN DU CANCER
    95. Cottu, PH; Extra, JM; Espie, M; Marolleau, J; de Roquancourt, A; Makke, J; Miclea, JM; Laurence, V; Mayeur, D; Lerebours, F; Cuvier, C; Marty, M
      High-dose sequential epirubicin and cyclophosphamide with peripheral bloodstem cell support for advanced breast cancer: results of a phase II study

      BRITISH JOURNAL OF CANCER
    96. Will, BP; Nobrega, KM; Berthelot, JM; Flanagan, W; Wolfson, MC; Logan, DM; Evans, WK
      First do no harm: extending the debate on the provision of preventive tamoxifen

      BRITISH JOURNAL OF CANCER
    97. Porrata, LF; Adjei, AA
      The pharmacologic basis of high dose chemotherapy with haematopoietic stemcell support for solid tumours

      BRITISH JOURNAL OF CANCER
    98. Marttunen, MB; Cacciatore, B; Hietanen, P; Pyrhonen, S; Tiitinen, A; Wahlstrom, T; Ylikorkala, O
      Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women

      BRITISH JOURNAL OF CANCER
    99. Prasad, AR; Divine, G; Zarbo, RJ
      Two-color, cytokeratin-labeled DNA flow cytometric analysis of 332 breast cancers - Lack of prognostic value with 12-year follow-up

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    100. Yo, IS; Opelka, FG; Bolton, JS; Fuhrman, GM
      A critical appraisal of treatment for T3N0 colon cancer

      AMERICAN SURGEON


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 14:17:32